Dishman Carbogen Amcis Ltd. Share Price

Dishman Carbogen Swiss Unit Secures Clean USFDA Inspection

Dishman Carbogen Amcis Limited has achieved a significant regulatory milestone, with its Swiss subsidiary, CARBOGEN AMCIS AG, completing its first U.S. FDA inspection at the Vionnaz manufacturing facility with zero Form 483 observations. Key Highlights: Regulatory Excellence: The clean audit validates the facility's adherence to stringent global quality standards, ensuring all major manufacturing sites of the company remain fully compliant with leading health agencies. Q1 FY27 Financial Pressure: This operational win contrasts with a challenging quarter. The company reported a consolidated net loss of ₹57.88 crore (reversing a ₹23.41 crore profit in Q1 FY26) and a 5.05% YoY dip in total income to ₹695.80 crore. Liquidity Management: To shore up working capital following the Q1 results, the board has approved a ₹75 crore fundraising via Non-Convertible Debentures (NCDs). Strategic Rationale: The spotless compliance record is vital for maintaining an active CDMO (Contract Development and Manufacturing Organization) pipeline. It directly supports the company's ability to realize approximately CHF 10 million in deferred project revenues expected in H2 FY27, as global innovator pharma clients regain the confidence to execute previously delayed orders. Market Implications: While this zero-observation clearance is a strong positive operational trigger that mitigates compliance risk, it may only partially offset near-term market concerns regarding the sharp profitability decline. Sustained bottom-line recovery and effective debt management will remain critical for a long-term valuation rerating, even as the broader structural turnaround thesis remains intact.

Dishman Carbogen Amcis Limited – SWOT Analysis

Dishman Carbogen Amcis continues to represent a compelling long-term opportunity within the global pharmaceutical services space

n 1st November MTTs, PNB given at Rs.98 touched Rs.111 & still looks good, Pennar Inds., given at Rs.195 touched Rs.227 & still looks very good. In 9th November MTTs, PIX given at Rs.1683 touched Rs.2796 - a superb gain of 66% in less than month. In 16th November MTTs, Dishman Carbogen Amcis given at Rs.212 touched Rs.276 - a gain of 30%, International Travel House given at Rs.617 touched Rs.709, Morepen Laboratories given at Rs.75.62 touched Rs.88 & still looks good, Nahar Polyfilms given at Rs.256 touched Rs299., Power Finance Corporation given at Rs.455 touched Rs.523, Sika Interplant Systems given at Rs.2397 touched Rs.2598, Somi Conveyor Beltings given at Rs.161 touched Rs.183 & now at Rs.171 looks very good, Va Tech Wabag given at Rs.1674 touched Rs.1919 during the week. In 23rd November MTTs, Lactose (India) given at Rs.170 touched Rs.246 - a gain of 45%, Mangalam Drugs & Organics given at Rs.106 touched Rs.128, Narmada Gelatines given at Rs.343 touched Rs.415, Sree Rayalaseema Hi-Strength Hypo given at Rs.671 touched Rs.733 during the week. Last week in MTTs 30th November HCC given at Rs.43 touched Rs.48 and still looks good, Himtek given at Rs.230 touched Rs.242, Indian Toners given at Rs.288 touched Rs.316, NRB Bearings given at Rs.292 touched Rs.314, Ruchira Papers given at Rs.131 touched Rs.143, Shri Bajrang Alliance given at Rs.199 touched Rs.241 - a gain of 21%, Tyche Industries given at Rs.190 touched Rs.224 during the week. GIPCL posted higher H1 PAT of Rs.102.50 cr. with an EPS of Rs.6.78 and paid 39.5% dividend for FY24. At Rs. 212, it's one of the cheapest in the power sector, well below its 52-week high of Rs. 270. Sandur Manganese Iron Ores posted 165% higher H1 PAT with 74.22% promoter stake and 9.35% from HNIs. It expanded mining by 400% and acquired Arjas Steel. Stock at Rs. 527 looks attractive, well below its 52-week high of Rs. 636.